Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Genprex, Inc.

Equities

GNPX

US3724462037

Delayed Nasdaq
Other stock markets
 11:00:00 03/07/2024 pm IST 		5-day change 1st Jan Change
1.91 USD -3.05% Intraday chart for Genprex, Inc. -2.55% -79.24%
15/05 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/05 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENPREX, INC.
Bio Therapeutic Drugs
-3.05%-2.55%-79.24%-95.03%-95.87% 4M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. Relative Strength Chart